Pasadena, CA, United States of America

David Bunck

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of David Bunck

Introduction

David Bunck is an accomplished inventor based in Pasadena, CA. He has made significant contributions to the field of biotechnology, particularly in the development of capture agents for IL-17F and IL-17A. With a total of 2 patents, his work has implications for various applications in medical diagnostics and research.

Latest Patents

David Bunck's latest patents include innovations related to IL-17F and IL-17A-specific capture agents. The first patent provides stable peptide-based IL-17F and IL-17A capture agents and methods of use as detection agents. This application also outlines methods for manufacturing IL-17F capture agents. The second patent focuses on IL-17F-specific capture agents, compositions, and methods of using and making them, further emphasizing the stability and utility of these agents in detection applications.

Career Highlights

Throughout his career, David has worked with notable organizations such as Indi Molecular, Inc. and the California Institute of Technology. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

David has collaborated with esteemed colleagues, including James R. Heath and Heather Dawn Agnew. These partnerships have fostered an environment of innovation and have led to advancements in the technologies he has developed.

Conclusion

David Bunck's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of diagnostic tools and methods in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…